Stryker wins $70M judgment in wound debridement patent case against Zimmer
A Michigan jury awards $70 million plus royalties to Stryker in a patent infringement case against rival Zimmer Holdings over wound debridement devices.
A federal jury in Michigan yesterday awarded $70 million in damages plus royalties to Stryker  (NYSE:SYK ) in a patent infringement lawsuit against Zimmer  (NYSE:ZMH ) over wound debridement devices.
Kalamazoo, Mich.-based Stryker sued orthopedics rival Zimmer in December 2010, alleging infringement of 3 patents covering wound debridement technology with Zimmer's Pulsavac Plus device.
Yesterday a jury in the U.S. District Court for Western Michigan awarded $70 million to Stryker in damages, ruling that Zimmer infringed all 3 patents, according to court documents.